Back

Clinical significance of new-onset atrial fibrillation in patients with coronary artery or peripheral artery disease: results from the COMPASS trial

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: clinical 1 Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Alexander Philipp Benz

Population Health Research Institute, Hamilton (Canada)

6 More presentations in this session

Presentation thumbnail
Association of the pattern of new-onset post-operative atrial fibrillation with adverse clinical events over 1 year follow-up: insights from the VISION Cardiac Surgery Cohort
Doctor W. McIntyre (Hamilton, CA)
Abstract Slides Video
Presentation thumbnail
Dietary sodium intake and atrial myopathy
Associate Professor L. Johnson (Malmo, SE)
Abstract Slides Video
Presentation thumbnail
Assessing heart rate fragmentation to predict atrial fibrillation in the general population aged 65
Doctor J. Guichard (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Timing of detection of atrial fibrillation recurrence in patients with transient new-onset atrial fibrillation detected during hospitalization for noncardiac surgery or medical illness
Doctor W. McIntyre (Hamilton, CA)
Abstract Slides Video
Presentation thumbnail
Quality of life when switching from a vitamin K antagonist to non-vitamin K antagonist oral anticoagulation in frail older patients with atrial fibrillation
Doctor S. van Doorn (Utrecht, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: clinical 1
Video

The Event

Event poster

EHRA 2024

7 April - 9 April 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources